EFFICACY OF CHLORHEXIDINE MOUTHRINSE IN THE CONTROL OF DENTAL PLAQUE AND GINGIVITIS: A PRISMA-GUIDED SYSTEMATIC REVIEW OF SYSTEMATIC REVIEWS
Keywords:
chlorhexidine; mouthwash; dental plaque; gingivitis; systematic review; PRISMAAbstract
Background: Chlorhexidine (CHX) has been used as an adjunct to mechanical plaque control since the early 1970s, yet the size and clinical relevance of its effect, and its trade-offs against alternative antiseptics, remain debated. Objective: To synthesise evidence from published systematic reviews on the efficacy and adverse effects of CHX mouthrinses for dental plaque and gingivitis. Methods: A systematic review of systematic reviews was conducted following PRISMA 2020 principles. Targeted searches (October 2026) identified systematic reviews of randomised controlled trials (RCTs) evaluating CHX mouthrinses. Eight reviews published between 2006 and 2025 were included. Effect estimates and risk-of-bias judgements were extracted as reported, and a narrative synthesis was performed; no pooling was undertaken because of overlap among primary trials. Results: CHX mouthrinse consistently reduced plaque: the Cochrane review reported a standardised mean difference (SMD) of −1.45 (95% CI −1.90 to −1.00) at 4–6 weeks and −1.59 (−1.89 to −1.29) at 6 months. Gingival inflammation fell by 0.21 points (95% CI 0.11–0.31) on the 0–3 Gingival Index in mild gingivitis, a change the authors judged of limited clinical importance, with moderate reductions in bleeding. Extrinsic tooth staining increased (SMD 1.07; 0.80–1.34). No consistent advantage of 0.2% over 0.12% was shown. Compared with essential-oil rinses, CHX produced greater plaque reduction but no difference in gingival inflammation; compared with cetylpyridinium chloride, a small plaque advantage appeared only in non-brushing models. Most primary trials were at high risk of bias. Conclusions: CHX is a highly effective short-term anti-plaque adjunct, with a modest effect on gingival indices at low baseline inflammation and predictable local adverse effects. Long-term, low-risk-of-bias trials with standardised outcomes are needed.
References
1.Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 World Workshop. J Periodontol. 2018;89(Suppl 1):S74–84.
2.Löe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol. 1965;36:177–87.
3.Löe H, Schiøtt CR. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. J Periodontal Res. 1970;5(2):79–83.
4.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
5.Gunsolley JC. A meta-analysis of six-month studies of antiplaque and antigingivitis agents. J Am Dent Assoc. 2006;137(12):1649–57.
6.Berchier CE, Slot DE, Van der Weijden GA. The efficacy of 0.12% chlorhexidine mouthrinse compared with 0.2% on plaque accumulation and periodontal parameters: a systematic review. J Clin Periodontol. 2010;37(9):829–39.
7.Van Leeuwen MPC, Slot DE, Van der Weijden GA. Essential oils compared to chlorhexidine with respect to plaque and parameters of gingival inflammation: a systematic review. J Periodontol. 2011;82(2):174–94.
8.Van Strydonck DAC, Slot DE, Van der Velden U, Van der Weijden F. Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. J Clin Periodontol. 2012;39(11):1042–55.
9.James P, Worthington HV, Parnell C, Harding M, Lamont T, Cheung A, et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev. 2017;3:CD008676.
10.Figuero E, Herrera D, Tobías A, Serrano J, Roldán S, Escribano M, et al. Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and network meta-analyses. J Clin Periodontol. 2019;46(7):723–39.
11.Figuero E, Roldán S, Serrano J, Escribano M, Martín C, Preshaw PM. Efficacy of adjunctive therapies in patients with gingival inflammation: a systematic review and meta-analysis. J Clin Periodontol. 2020;47(Suppl 22):125–43.
12.[Authors to be added]. The effect of cetylpyridinium chloride compared to chlorhexidine mouthwash on scores of plaque and gingivitis: a systematic review and meta-analyses. Int J Dent Hyg. 2025;23(4):665–81.
13.Bescos R, Ashworth A, Cutler C, Brookes ZL, Belfield L, Rodiles A, et al. Effects of chlorhexidine mouthwash on the oral microbiome. Sci Rep. 2020;10:5254.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal